Carfilzomib, Dexamethasone, and Daratumumab Myeloma Treatment Alternative
February 1st 2021Hang Quach, MBBS(Hons), SpecCertOC, FRACP, FRCPA, MD, talks about the use of carfilzomib, dexamethasone, and daratumumab as a cheaper alternative for treating relapsed or refractory multiple myeloma as seen in the ALLG MM018/ AMN002 study.
Watch
Combination of Venetoclax and Hypomethylating Agents Show Efficacy in AML
February 1st 2021Danielle Hammond, MD, discusses the results from a retrospective review of patients with acute myeloid leukemia treated over the last 6 years with a combination of venetoclax and either decitabine or azacitadine.
Watch